TSXV - Delayed Quote
CAD
Sharp Therapeutics Corp. (SHRX.V)
1.3700
0.0000
(0.00%)
At close: September 21 at 11:31:12 AM EDT
Loading chart for SHRX.V
- Previous Close
1.3700 - Open
1.3700 - Bid 0.2800 x --
- Ask 1.1900 x --
- Day's Range
1.3700 - 1.3700 - 52 Week Range
0.9100 - 5.0000 - Volume
50 - Avg. Volume
48 - Market Cap (intraday)
43.259M - Beta (5Y Monthly) -1.11
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2800 - Earnings Date (est.) Nov 26, 2026
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
SHRX.V
45.20%
S&P/TSX Composite index (^GSPTSE)
12.35%
1-Year Return
SHRX.V
59.94%
S&P/TSX Composite index (^GSPTSE)
18.31%
3-Year Return
SHRX.V
37.73%
S&P/TSX Composite index (^GSPTSE)
82.41%
5-Year Return
SHRX.V
37.73%
S&P/TSX Composite index (^GSPTSE)
69.11%
Statistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-131.63%
-
Return on Equity (ttm)
-3,762.21%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-5.18M
-
Diluted EPS (ttm)
-0.2800
Balance Sheet and Cash Flow
-
Total Cash (mrq)
104.68k
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-2.29M
